SCHEMBL20766190

SCHEMBL20766190

N#Cc1cc(S(=O)(=O)CCC(=O)O)ccc1Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.43
▸ KIF11 P52732 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ AKR1C3 P42330 1/20 0.40
▸ AKR1C2 P52895 1/20 0.40
▸ AR P10275 2/20 0.39
▸ FBP1 P09467 1/20 0.39
▸ TAS2R14 Q9NYV8 2/20 0.39
▸ RORC P51449 1/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ PLA2G7 Q13093 1/20 0.37
▸ KDM1A O60341 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ PTPN6 P29350 1/20 0.37
▸ PTPN11 Q06124 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20779639 0.89 MMP1 (0.44) MMP1KIF11AKR1C3AKR1C2AR
SCHEMBL20779642 0.78 TEAD1 (0.56) KIF11ALDH1A1AKR1C3AKR1C2PLA2G7
SCHEMBL30410558 0.78 TEAD1 (0.56) KIF11ALDH1A1AKR1C3AKR1C2PLA2G7
SCHEMBL20552520 0.72 KIF11 (0.45) KDM4EKIF11ALDH1A1AKR1C3AKR1C2
SCHEMBL20552318 0.71 LRRK2 (0.50) KDM4EKIF11ALDH1A1AKR1C3AKR1C2
SCHEMBL21091532 0.71 AKR1C3 (0.50) KDM4EKIF11AKR1C3AKR1C2TAS2R14
SCHEMBL29074795 0.70 BCL6 (0.59) KDM4EKIF11ALDH1A1FBP1
SCHEMBL20767101 0.70 KIF11 (0.45) KDM4EKIF11ALDH1A1AKR1C3AKR1C2
SCHEMBL20553084 0.70 SLC22A12 (0.47) KDM4EKIF11ALDH1A1AKR1C3AKR1C2
SCHEMBL20552788 0.70 LRRK2 (0.49) KDM4EKIF11ALDH1A1AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3691623-A1 BENZOSULFONYL COMPOUNDS Vivace Therapeutics, Inc. (US) 2020-08-12 — — EP disclosed
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 — — WO disclosed
Send feedback